Question 1

What specific symptoms will I be monitored for during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the infusion of natriuretic peptides be administered?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

Question 3

What should I expect during the infusion process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks or side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial help improve understanding of headaches?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience a headache before the trial starts?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow clinical trial (NCT01637662). Contact the study team or your healthcare provider for specific answers.

What this study is about